Nicole Faust

Private Investment Firm North Rhine-Westphalia, Germany ·Founded 2001

Overview

Nicole Faust is a seasoned biotechnology executive with over 20 years of experience in cell and gene therapy. She is the Chief Executive Officer and Chief Scientific Officer of CEVEC Pharmaceuticals GmbH, a company specializing in the production of biopharmaceuticals using human cell-based expression systems. Under her leadership, CEVEC has developed the CAP®GT platform for scalable adeno-associated virus (AAV) vector production, which has been instrumental in advancing gene therapy applications. Prior to her tenure at CEVEC, Dr. Faust held leadership positions at Lonza and Taconic Biosciences, where she focused on cell line development and bioprocessing technologies. She holds a PhD in cell and molecular biology from the University of Freiburg and an MBA from Educatis University in Switzerland. Dr. Faust is an active member of the American Society for Gene and Cell Therapy and serves as the Chair of the Gene Therapy Advisory Committee of the Alliance for Regenerative Medicine. In 2022, CEVEC was acquired by Cytiva, a global leader in biomanufacturing solutions, further expanding the reach and impact of Dr. Faust's work in the biotechnology sector. Her strategic vision and scientific expertise continue to drive innovation in the field of gene therapy and bioprocessing.

Investment Focus

  • Strong scientific leadership
  • Innovative biotechnological solutions
  • Scalable manufacturing platforms
  • Advancements in gene therapy applications
  • Global market expansion potential

Portfolio Companies

Evox TherapeuticsBiogenPeppermint Ventures

Get the full list of 54,000+ investors

Nicole Faust and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription
  • All 54,000+ investors — VC firms, private equity, family offices and angels
  • The key person to contact at each one, with their job title
  • Their work email address
  • Their phone number
  • Their LinkedIn profile
  • Delivered as a single .xlsx file — download it as many times as you like
Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about Nicole Faust

What sectors does Nicole Faust invest in?

Nicole Faust invests in Healthcare, Life Sciences, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in North Rhine-Westphalia, Germany. Nicole Faust is listed as a private investment firm in the ConnectSafely investor database.

What stage does Nicole Faust invest at?

Nicole Faust backs companies at Early Stage, Growth and Late Stage, writing cheques of 1M - 50M.

Which regions does Nicole Faust invest in?

Nicole Faust invests across United States, United Kingdom, Germany, France, Italy and Denmark.

What companies has Nicole Faust invested in?

Nicole Faust's portfolio includes Evox Therapeutics, Biogen and Peppermint Ventures.

Last updated · Source: ConnectSafely investor database